ConductScience.org, home

Trial · NCT06173869

Registered outcomes16

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of Oocytes RetrievedOn day of oocyte retrieval (up to 22 days after start of stimulation)
SecondaryNumber of Follicles on Stimulation Day 6 and End-of-stimulationStimulation day 6 and end-of-stimulation (maximum stimulation day 20)
SecondarySerum Concentrations of Estradiol on Stimulation Day 6 and End-of-stimulationstimulation day 6 and end-of-stimulation (maximum stimulation day 20)
SecondarySerum Concentrations of Progesterone on Stimulation Day 6 and End-of-stimulationstimulation day 6 and end-of-stimulation (maximum stimulation day 20)
SecondaryNumber of Fertilised OocytesOn day 1 after oocyte retrieval (up to 23 days after start of stimulation)
SecondaryFertilisation RateOn day 1 after oocyte retrieval (up to 23 days after start of stimulation)
SecondaryNumber of Embryos (Total and Quality)Day 3 after oocyte retrieval
SecondaryTotal Gonadotropin DoseUp to 20 stimulation days
SecondaryNumber of Stimulation DaysUp to 20 stimulation days
SecondaryPositive βhCG (Positive Serum βhCG Test 13-15 Days After Transfer) Rate13-15 days after transfer
SecondaryClinical Pregnancy (at Least One Gestational Sac 5-6 Weeks After Transfer) Rate5-6 weeks after transfer
SecondaryVital Pregnancy (at Least One Intrauterine Gestational Sac With Fetal Heart Beat 5-6 Weeks After Transfer) Rate5-6 weeks after transfer
SecondaryImplantation Rate5-6 weeks after transferThe implantation rate was defined as the number of gestational sacs 5-6 weeks after transfer divided by number of embryos transferred.
SecondaryOngoing Pregnancy (at Least One Intrauterine Viable Fetus 10-11 Weeks After Transfer) Rate10-11 weeks after transfer
SecondaryOngoing Implantation Rate (Number of Intrauterine Viable Fetuses 10-11 Weeks After Transfer Divided by Number of Embryos Transferred)10-11 weeks after transferThe ongoing implantation rate was defined as the number of intrauterine viable fetuses 10-11 weeks after transfer divided by the number of embryos transferred.
SecondaryEarly Ovarian Hyperstimulation Syndrome (OHSS), Late OHSS, and Total OHSS (All Overall and by Grade)
≤9 days after triggering of final follicular maturation (early OHSS), >9 days after triggering of final follicular maturation until 21-28 days after last IMP dose or up to ongoing pregnancy 8-9 weeks after transfer in pregnant participants (late OHSS)
Early OHSS was defined as OHSS with onset ≤9 days after triggering of final follicular maturation. Late OHSS was defined as OHSS with onset \>9 days after triggering of final follicular maturation. Total OHSS measure the incidence of OHSS both early and late.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06173869/registered